The FDA has approved Lilly’s Verzenio, making it the third market ... until the dreaded FDA Complete Response Letter came back in April. Lilly and its partner Incyte have now been offered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback